| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.37e-09 | 16 | 78 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | calcium ion binding | SNED1 VLDLR EGF MEGF6 CCBE1 NCAN LRP2 LRP4 NID1 CUBN F2 LTBP4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 | 3.54e-09 | 749 | 78 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.55e-08 | 21 | 78 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.00e-06 | 85 | 78 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 8.99e-05 | 4 | 78 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.41e-05 | 188 | 78 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 3.43e-04 | 35 | 78 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 3.43e-04 | 35 | 78 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | integrin binding | 6.15e-04 | 175 | 78 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | hemoglobin binding | 8.10e-04 | 11 | 78 | 2 | GO:0030492 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.14e-03 | 13 | 78 | 2 | GO:0008046 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | JADE2 NCAN L1CAM LRP2 LRP4 RELA F2 LDLR NOTCH1 NOTCH2 EPHA7 SORL1 | 5.02e-07 | 515 | 78 | 12 | GO:0050767 |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 5.79e-07 | 80 | 78 | 6 | GO:2000179 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | JADE2 NCAN L1CAM LRP2 LRP4 RELA F2 LDLR NOTCH1 NOTCH2 EPHA7 SORL1 | 3.77e-06 | 625 | 78 | 12 | GO:0051960 |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 1.23e-05 | 135 | 78 | 6 | GO:2000177 | |
| GeneOntologyBiologicalProcess | endocytic hemoglobin import into cell | 1.41e-05 | 2 | 78 | 2 | GO:0020028 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 4.05e-05 | 337 | 78 | 8 | GO:0006898 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 4.23e-05 | 3 | 78 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 4.97e-05 | 173 | 78 | 6 | GO:0050768 | |
| GeneOntologyBiologicalProcess | regulation of cell development | SMAP1 JADE2 NCAN L1CAM LRP2 LRP4 RELA CD46 F2 LDLR NOTCH1 NOTCH2 EPHA7 SORL1 | 5.50e-05 | 1095 | 78 | 14 | GO:0060284 |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 7.01e-05 | 184 | 78 | 6 | GO:0051961 | |
| GeneOntologyBiologicalProcess | mitral valve formation | 1.40e-04 | 5 | 78 | 2 | GO:0003192 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.40e-04 | 5 | 78 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.52e-04 | 71 | 78 | 4 | GO:0002347 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.58e-04 | 410 | 78 | 8 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | FLNA TIGIT TNC L1CAM LAMA3 NID1 RELA CD46 MUC4 NOTCH1 LAX1 EPHA7 | 1.78e-04 | 927 | 78 | 12 | GO:0030155 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | NPHS1 FLNA ITGBL1 TIGIT L1CAM LAMA3 RELA CD46 MUC4 SVEP1 NOTCH1 LAX1 EPHA7 | 1.86e-04 | 1077 | 78 | 13 | GO:0098609 |
| GeneOntologyBiologicalProcess | limb development | 2.05e-04 | 224 | 78 | 6 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 2.05e-04 | 224 | 78 | 6 | GO:0048736 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 2.54e-04 | 233 | 78 | 6 | GO:0061351 | |
| GeneOntologyBiologicalProcess | regulation of gliogenesis | 2.70e-04 | 151 | 78 | 5 | GO:0014013 | |
| GeneOntologyBiologicalProcess | cell junction organization | NPHS1 GABRG2 VLDLR FLNA INSYN1 TNC NCAN L1CAM LAMA3 LRP4 SVEP1 EPHA7 | 2.81e-04 | 974 | 78 | 12 | GO:0034330 |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 2.86e-04 | 34 | 78 | 3 | GO:0060977 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 2.93e-04 | 7 | 78 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 3.62e-04 | 89 | 78 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 3.84e-04 | 354 | 78 | 7 | GO:0050769 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 3.90e-04 | 8 | 78 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 3.90e-04 | 8 | 78 | 2 | GO:0045959 | |
| GeneOntologyBiologicalProcess | negative regulation of glial cell differentiation | 4.31e-04 | 39 | 78 | 3 | GO:0045686 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 4.65e-04 | 40 | 78 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | ZCCHC18 EGF CCBE1 ERO1A LRP2 LRP4 RELA LTBP4 SVEP1 NOTCH1 NOTCH2 EPHA7 SORL1 | 4.72e-04 | 1186 | 78 | 13 | GO:0007167 |
| GeneOntologyBiologicalProcess | atrioventricular node development | 5.00e-04 | 9 | 78 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | atrioventricular valve formation | 5.00e-04 | 9 | 78 | 2 | GO:0003190 | |
| GeneOntologyBiologicalProcess | kidney development | 5.16e-04 | 372 | 78 | 7 | GO:0001822 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 5.56e-04 | 270 | 78 | 6 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of astrocyte differentiation | 5.76e-04 | 43 | 78 | 3 | GO:0048710 | |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 6.16e-04 | 44 | 78 | 3 | GO:0002052 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 6.23e-04 | 10 | 78 | 2 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 6.23e-04 | 10 | 78 | 2 | GO:1902966 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 6.23e-04 | 10 | 78 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 6.23e-04 | 10 | 78 | 2 | GO:0030450 | |
| GeneOntologyBiologicalProcess | cobalamin transport | 6.23e-04 | 10 | 78 | 2 | GO:0015889 | |
| GeneOntologyBiologicalProcess | renal system development | 6.43e-04 | 386 | 78 | 7 | GO:0072001 | |
| GeneOntologyBiologicalProcess | regulation of glial cell differentiation | 6.53e-04 | 104 | 78 | 4 | GO:0045685 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 6.84e-04 | 185 | 78 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 6.84e-04 | 185 | 78 | 5 | GO:0035108 | |
| GeneOntologyBiologicalProcess | axon development | 6.98e-04 | 642 | 78 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | axon guidance | 7.37e-04 | 285 | 78 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 7.51e-04 | 286 | 78 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | FLNA COL11A2 PNPLA6 TNC LRP2 LAMA3 LRP4 RELA SIK3 CERT1 NOTCH1 NOTCH2 ZFPM2 | 8.89e-04 | 1269 | 78 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryo development | TBC1D32 ZFP42 NSD1 LRP2 LAMA3 LRP4 CUBN CERT1 LRP1B KAT14 GINS1 NOTCH1 NOTCH2 ZFPM2 | 9.02e-04 | 1437 | 78 | 14 | GO:0009790 |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 9.07e-04 | 197 | 78 | 5 | GO:0030509 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 9.09e-04 | 12 | 78 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 9.09e-04 | 12 | 78 | 2 | GO:0002924 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 9.90e-04 | 817 | 78 | 10 | GO:0048514 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | FLNA PNPLA6 EGF TNC CCBE1 LRP2 RELA LDLR NOTCH1 NOTCH2 ZFPM2 EPHA7 | 1.01e-03 | 1125 | 78 | 12 | GO:0035239 |
| GeneOntologyBiologicalProcess | vasculature development | FLNA PNPLA6 EGF CCBE1 LRP2 RELA LDLR SVEP1 NOTCH1 NOTCH2 ZFPM2 | 1.01e-03 | 969 | 78 | 11 | GO:0001944 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.02e-03 | 418 | 78 | 7 | GO:0051962 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 1.07e-03 | 13 | 78 | 2 | GO:0048845 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.10e-03 | 685 | 78 | 9 | GO:0050808 | |
| GeneOntologyBiologicalProcess | hair follicle development | 1.22e-03 | 123 | 78 | 4 | GO:0001942 | |
| GeneOntologyBiologicalProcess | peptidyl-proline hydroxylation | 1.25e-03 | 14 | 78 | 2 | GO:0019511 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to endosome | 1.25e-03 | 14 | 78 | 2 | GO:1905668 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.25e-03 | 14 | 78 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.25e-03 | 14 | 78 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 1.25e-03 | 14 | 78 | 2 | GO:0045916 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 1.25e-03 | 14 | 78 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet activation | 1.25e-03 | 14 | 78 | 2 | GO:0010572 | |
| GeneOntologyBiologicalProcess | gliogenesis | 1.29e-03 | 435 | 78 | 7 | GO:0042063 | |
| GeneOntologyBiologicalProcess | molting cycle process | 1.34e-03 | 126 | 78 | 4 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 1.34e-03 | 126 | 78 | 4 | GO:0022405 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.34e-03 | 215 | 78 | 5 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.34e-03 | 215 | 78 | 5 | GO:0071773 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 1.36e-03 | 321 | 78 | 6 | GO:0010001 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 1.36e-03 | 321 | 78 | 6 | GO:0003007 | |
| GeneOntologyBiologicalProcess | mitral valve morphogenesis | 1.44e-03 | 15 | 78 | 2 | GO:0003183 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to endosome | 1.44e-03 | 15 | 78 | 2 | GO:1905666 | |
| GeneOntologyBiologicalProcess | regulation of triglyceride catabolic process | 1.44e-03 | 15 | 78 | 2 | GO:0010896 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue morphogenesis | 1.45e-03 | 59 | 78 | 3 | GO:0055010 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.47e-03 | 445 | 78 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.54e-03 | 131 | 78 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.55e-03 | 580 | 78 | 8 | GO:0022407 | |
| GeneOntologyBiologicalProcess | mitral valve development | 1.64e-03 | 16 | 78 | 2 | GO:0003174 | |
| GeneOntologyBiologicalProcess | protein localization to early endosome | 1.64e-03 | 16 | 78 | 2 | GO:1902946 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 1.64e-03 | 16 | 78 | 2 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 1.64e-03 | 16 | 78 | 2 | GO:0002890 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.68e-03 | 134 | 78 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | negative regulation of gliogenesis | 1.68e-03 | 62 | 78 | 3 | GO:0014014 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | VLDLR FLNA JADE2 L1CAM LRP2 LAMA3 LRP4 F2 CERT1 NOTCH1 NOTCH2 EPHA7 | 1.68e-03 | 1194 | 78 | 12 | GO:0000902 |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 1.75e-03 | 63 | 78 | 3 | GO:0003179 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.77e-03 | 883 | 78 | 10 | GO:0070848 | |
| GeneOntologyCellularComponent | extracellular matrix | NPHS1 SNED1 COL11A2 FCGBP MEGF6 TNC CCBE1 NCAN L1CAM LAMA3 NID1 F2 LTBP4 MUC4 SVEP1 | 2.02e-08 | 656 | 79 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NPHS1 SNED1 COL11A2 FCGBP MEGF6 TNC CCBE1 NCAN L1CAM LAMA3 NID1 F2 LTBP4 MUC4 SVEP1 | 2.10e-08 | 658 | 79 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.78e-06 | 530 | 79 | 11 | GO:0062023 | |
| GeneOntologyCellularComponent | cell surface | HYAL4 VLDLR ITGBL1 TIGIT L1CAM LRP2 LRP4 CORIN CD46 CUBN F2 LDLR NOTCH1 NOTCH2 SORL1 | 1.52e-05 | 1111 | 79 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | receptor complex | 6.55e-05 | 581 | 79 | 10 | GO:0043235 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 2.40e-04 | 80 | 79 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | cell-substrate junction | 2.67e-04 | 443 | 79 | 8 | GO:0030055 | |
| GeneOntologyCellularComponent | axonal growth cone | 6.58e-04 | 45 | 79 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 7.59e-04 | 11 | 79 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | Golgi lumen | 7.78e-04 | 109 | 79 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.07e-03 | 13 | 79 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | basement membrane | 1.18e-03 | 122 | 79 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | focal adhesion | 1.22e-03 | 431 | 79 | 7 | GO:0005925 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.45e-03 | 59 | 79 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.85e-03 | 17 | 79 | 2 | GO:0098637 | |
| Domain | EGF | TMEFF1 HYAL4 SNED1 VLDLR ITGBL1 FCGBP EGF MEGF6 TNC CCBE1 NCAN LRP2 LAMA3 LRP4 NID1 CUBN LTBP4 MUC4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 SORL1 | 3.27e-27 | 235 | 78 | 24 | SM00181 |
| Domain | EGF_2 | TMEFF1 HYAL4 SNED1 VLDLR ITGBL1 EGF MEGF6 TNC CCBE1 NCAN LRP2 LAMA3 LRP4 NID1 CUBN LTBP4 MUC4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 EPHA7 SORL1 | 6.19e-26 | 265 | 78 | 24 | PS01186 |
| Domain | EGF-like_dom | TMEFF1 SNED1 VLDLR ITGBL1 FCGBP EGF MEGF6 TNC CCBE1 NCAN LRP2 LAMA3 LRP4 NID1 CUBN LTBP4 MUC4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 SORL1 | 4.81e-25 | 249 | 78 | 23 | IPR000742 |
| Domain | EGF-like_CS | TMEFF1 SNED1 VLDLR EGF MEGF6 TNC CCBE1 NCAN LRP2 LAMA3 LRP4 NID1 CUBN ZNRF4 LTBP4 MUC4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 EPHA7 SORL1 | 1.44e-24 | 261 | 78 | 23 | IPR013032 |
| Domain | EGF_1 | TMEFF1 HYAL4 SNED1 VLDLR ITGBL1 EGF MEGF6 TNC CCBE1 NCAN LRP2 LAMA3 LRP4 NID1 CUBN LTBP4 MUC4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 | 2.72e-23 | 255 | 78 | 22 | PS00022 |
| Domain | EGF_Ca-bd_CS | SNED1 VLDLR EGF MEGF6 CCBE1 NCAN LRP2 LRP4 NID1 CUBN LTBP4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 | 1.02e-21 | 97 | 78 | 16 | IPR018097 |
| Domain | EGF_CA | SNED1 VLDLR EGF MEGF6 CCBE1 NCAN LRP2 LRP4 NID1 CUBN LTBP4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 | 1.44e-21 | 99 | 78 | 16 | PS01187 |
| Domain | ASX_HYDROXYL | SNED1 VLDLR EGF MEGF6 CCBE1 NCAN LRP2 LRP4 NID1 CUBN LTBP4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 | 1.71e-21 | 100 | 78 | 16 | PS00010 |
| Domain | EGF_3 | TMEFF1 SNED1 VLDLR EGF MEGF6 TNC CCBE1 NCAN LRP2 LRP4 NID1 CUBN LTBP4 MUC4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 SORL1 | 4.54e-21 | 235 | 78 | 20 | PS50026 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | SNED1 VLDLR EGF MEGF6 CCBE1 NCAN LRP2 LRP4 NID1 CUBN LTBP4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 | 4.59e-21 | 106 | 78 | 16 | IPR000152 |
| Domain | EGF_CA | SNED1 VLDLR EGF MEGF6 CCBE1 NCAN LRP2 LRP4 NID1 CUBN LTBP4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 | 4.88e-20 | 122 | 78 | 16 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | SNED1 VLDLR EGF MEGF6 CCBE1 NCAN LRP2 LRP4 NID1 CUBN LTBP4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 | 6.40e-20 | 124 | 78 | 16 | IPR001881 |
| Domain | EGF_CA | VLDLR EGF MEGF6 CCBE1 LRP2 LRP4 NID1 CUBN LTBP4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 | 5.14e-19 | 86 | 78 | 14 | PF07645 |
| Domain | Growth_fac_rcpt_ | VLDLR EGF MEGF6 TNC LRP2 LAMA3 LRP4 NID1 CUBN LTBP4 LRP1B LDLR SVEP1 NOTCH1 NOTCH2 EPHA7 | 2.82e-18 | 156 | 78 | 16 | IPR009030 |
| Domain | EGF | SNED1 VLDLR EGF MEGF6 TNC NCAN LRP2 LRP4 NID1 CUBN MUC4 LRP1B SVEP1 NOTCH1 NOTCH2 | 3.54e-18 | 126 | 78 | 15 | PF00008 |
| Domain | Ldl_recept_b | 1.88e-16 | 14 | 78 | 8 | PF00058 | |
| Domain | LDLRB | 1.88e-16 | 14 | 78 | 8 | PS51120 | |
| Domain | LY | 4.02e-16 | 15 | 78 | 8 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.02e-16 | 15 | 78 | 8 | IPR000033 | |
| Domain | - | 3.55e-12 | 39 | 78 | 8 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 4.42e-12 | 40 | 78 | 8 | IPR023415 | |
| Domain | Ldl_recept_a | 1.22e-11 | 45 | 78 | 8 | PF00057 | |
| Domain | - | 1.47e-11 | 46 | 78 | 8 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.47e-11 | 46 | 78 | 8 | IPR011042 | |
| Domain | LDLRA_1 | 2.11e-11 | 48 | 78 | 8 | PS01209 | |
| Domain | LDLRA_2 | 2.51e-11 | 49 | 78 | 8 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 2.51e-11 | 49 | 78 | 8 | IPR002172 | |
| Domain | LDLa | 2.51e-11 | 49 | 78 | 8 | SM00192 | |
| Domain | EGF_extracell | 5.44e-09 | 60 | 78 | 7 | IPR013111 | |
| Domain | EGF_2 | 5.44e-09 | 60 | 78 | 7 | PF07974 | |
| Domain | hEGF | 1.02e-07 | 28 | 78 | 5 | PF12661 | |
| Domain | NIDO_dom | 6.97e-07 | 5 | 78 | 3 | IPR003886 | |
| Domain | NIDO | 6.97e-07 | 5 | 78 | 3 | SM00539 | |
| Domain | NIDO | 6.97e-07 | 5 | 78 | 3 | PF06119 | |
| Domain | NIDO | 6.97e-07 | 5 | 78 | 3 | PS51220 | |
| Domain | cEGF | 3.92e-06 | 26 | 78 | 4 | IPR026823 | |
| Domain | cEGF | 3.92e-06 | 26 | 78 | 4 | PF12662 | |
| Domain | - | 1.13e-05 | 11 | 78 | 3 | 2.40.155.10 | |
| Domain | GFP-like | 1.13e-05 | 11 | 78 | 3 | IPR023413 | |
| Domain | FN3 | 1.22e-05 | 185 | 78 | 7 | SM00060 | |
| Domain | FN3_dom | 2.68e-05 | 209 | 78 | 7 | IPR003961 | |
| Domain | DUF3454 | 5.15e-05 | 3 | 78 | 2 | PF11936 | |
| Domain | DUF3454_notch | 5.15e-05 | 3 | 78 | 2 | IPR024600 | |
| Domain | DUF3454 | 5.15e-05 | 3 | 78 | 2 | SM01334 | |
| Domain | fn3 | 5.95e-05 | 162 | 78 | 6 | PF00041 | |
| Domain | CCP | 7.60e-05 | 54 | 78 | 4 | SM00032 | |
| Domain | SUSHI | 8.77e-05 | 56 | 78 | 4 | PS50923 | |
| Domain | - | 9.29e-05 | 663 | 78 | 11 | 2.60.40.10 | |
| Domain | Sushi_SCR_CCP_dom | 9.40e-05 | 57 | 78 | 4 | IPR000436 | |
| Domain | Notch | 1.03e-04 | 4 | 78 | 2 | IPR008297 | |
| Domain | NODP | 1.03e-04 | 4 | 78 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.03e-04 | 4 | 78 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.03e-04 | 4 | 78 | 2 | IPR010660 | |
| Domain | NOD | 1.03e-04 | 4 | 78 | 2 | PF06816 | |
| Domain | NOD | 1.03e-04 | 4 | 78 | 2 | SM01338 | |
| Domain | NODP | 1.03e-04 | 4 | 78 | 2 | SM01339 | |
| Domain | Ig-like_fold | 1.61e-04 | 706 | 78 | 11 | IPR013783 | |
| Domain | LNR | 1.71e-04 | 5 | 78 | 2 | PS50258 | |
| Domain | FN3 | 1.84e-04 | 199 | 78 | 6 | PS50853 | |
| Domain | Notch_dom | 3.57e-04 | 7 | 78 | 2 | IPR000800 | |
| Domain | Notch | 3.57e-04 | 7 | 78 | 2 | PF00066 | |
| Domain | SRCR_2 | 3.57e-04 | 7 | 78 | 2 | PF15494 | |
| Domain | NL | 3.57e-04 | 7 | 78 | 2 | SM00004 | |
| Domain | IG_FLMN | 7.58e-04 | 10 | 78 | 2 | SM00557 | |
| Domain | Filamin | 9.24e-04 | 11 | 78 | 2 | PF00630 | |
| Domain | Fol_N | 9.24e-04 | 11 | 78 | 2 | IPR003645 | |
| Domain | Ephrin_rec_like | 9.24e-04 | 11 | 78 | 2 | PF07699 | |
| Domain | FILAMIN_REPEAT | 9.24e-04 | 11 | 78 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 9.24e-04 | 11 | 78 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 9.24e-04 | 11 | 78 | 2 | IPR017868 | |
| Domain | FOLN | 9.24e-04 | 11 | 78 | 2 | SM00274 | |
| Domain | EGF_3 | 1.11e-03 | 12 | 78 | 2 | PF12947 | |
| Domain | EGF_dom | 1.11e-03 | 12 | 78 | 2 | IPR024731 | |
| Domain | zf-RING_2 | 1.34e-03 | 52 | 78 | 3 | PF13639 | |
| Domain | Sushi | 1.34e-03 | 52 | 78 | 3 | PF00084 | |
| Domain | TIL_dom | 1.52e-03 | 14 | 78 | 2 | IPR002919 | |
| Domain | VWD | 1.99e-03 | 16 | 78 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.99e-03 | 16 | 78 | 2 | IPR001846 | |
| Domain | VWFD | 1.99e-03 | 16 | 78 | 2 | PS51233 | |
| Domain | VWD | 1.99e-03 | 16 | 78 | 2 | PF00094 | |
| Domain | Actinin_actin-bd_CS | 4.12e-03 | 23 | 78 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 4.12e-03 | 23 | 78 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.12e-03 | 23 | 78 | 2 | PS00019 | |
| Pathway | WP_VITAMIN_B12_METABOLISM | 4.73e-06 | 54 | 65 | 5 | M39337 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.75e-05 | 300 | 65 | 8 | M610 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 7.27e-05 | 18 | 65 | 3 | M614 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.07e-04 | 5 | 65 | 2 | M27411 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.39e-04 | 66 | 65 | 4 | M18 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.03e-04 | 199 | 65 | 6 | M7253 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 3.10e-04 | 6 | 65 | 2 | M27068 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 3.48e-04 | 381 | 65 | 8 | M48063 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.12e-04 | 76 | 65 | 4 | M27219 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 4.22e-04 | 32 | 65 | 3 | M165 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.05e-09 | 21 | 79 | 5 | 21337463 | |
| Pubmed | 6.73e-09 | 175 | 79 | 8 | 28071719 | ||
| Pubmed | 3.29e-08 | 40 | 79 | 5 | 23362348 | ||
| Pubmed | Developmental regulation of LR11 expression in murine brain. | 4.50e-08 | 4 | 79 | 3 | 9726247 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FLNA ITGBL1 MEGF6 ZNRF3 TNC CCBE1 GPR162 LTBP4 NOTCH1 NOTCH2 ZFPM2 | 5.75e-08 | 560 | 79 | 11 | 21653829 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L CSDE1 ERO1A L1CAM LRP4 NID1 RELA CD46 EXOSC7 LRP1B LDLR NOTCH1 NOTCH2 CRTAP SORL1 | 7.38e-08 | 1201 | 79 | 15 | 35696571 |
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 19047013 | ||
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 18685438 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.21e-07 | 101 | 79 | 6 | 23382219 | |
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 2.24e-07 | 6 | 79 | 3 | 18957219 | |
| Pubmed | 3.92e-07 | 7 | 79 | 3 | 15162516 | ||
| Pubmed | 3.92e-07 | 7 | 79 | 3 | 12169628 | ||
| Pubmed | 9.38e-07 | 9 | 79 | 3 | 20005821 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA FLNC PNPLA6 MEGF6 ZNRF3 NLRX1 L1CAM NSD1 LRP4 LTBP4 LDLR NOTCH1 NOTCH2 | 1.19e-06 | 1105 | 79 | 13 | 35748872 |
| Pubmed | PJA2 VLDLR PNPLA6 ZNRF3 LRP2 LRP4 SIK3 LTBP4 KAT14 LDLR ZFP82 NOTCH2 SORL1 | 1.32e-06 | 1116 | 79 | 13 | 31753913 | |
| Pubmed | 1.34e-06 | 10 | 79 | 3 | 9184108 | ||
| Pubmed | Sterile Inflammation Enhances ECM Degradation in Integrin β1 KO Embryonic Skin. | 1.72e-06 | 38 | 79 | 4 | 27653694 | |
| Pubmed | 1.84e-06 | 11 | 79 | 3 | 24639464 | ||
| Pubmed | 2.10e-06 | 164 | 79 | 6 | 32409323 | ||
| Pubmed | 4.03e-06 | 14 | 79 | 3 | 15082773 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 4.03e-06 | 14 | 79 | 3 | 17389516 | |
| Pubmed | Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture. | 5.09e-06 | 2 | 79 | 2 | 24508387 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 7513709 | ||
| Pubmed | Notch controls generation and function of human effector CD8+ T cells. | 5.09e-06 | 2 | 79 | 2 | 23380742 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19393635 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21466361 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20069650 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15625786 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23978537 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 38008818 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18791690 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24376654 | ||
| Pubmed | Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. | 5.09e-06 | 2 | 79 | 2 | 17261636 | |
| Pubmed | Motch A and motch B--two mouse Notch homologues coexpressed in a wide variety of tissues. | 5.09e-06 | 2 | 79 | 2 | 8440332 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 11994745 | ||
| Pubmed | Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins. | 5.09e-06 | 2 | 79 | 2 | 10766831 | |
| Pubmed | Cubilin and megalin expression and their interaction in the rat intestine: effect of thyroidectomy. | 5.09e-06 | 2 | 79 | 2 | 11595644 | |
| Pubmed | Acute endotoxemia in mice induces downregulation of megalin and cubilin in the kidney. | 5.09e-06 | 2 | 79 | 2 | 22437417 | |
| Pubmed | Differential expression of Notch1 and Notch2 in developing and adult mouse brain. | 5.09e-06 | 2 | 79 | 2 | 7609614 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 33017398 | ||
| Pubmed | Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. | 5.09e-06 | 2 | 79 | 2 | 21285514 | |
| Pubmed | Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis. | 5.09e-06 | 2 | 79 | 2 | 18353145 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22205705 | ||
| Pubmed | Notch signaling induces cell cycle arrest in small cell lung cancer cells. | 5.09e-06 | 2 | 79 | 2 | 11306509 | |
| Pubmed | Correlation of asymmetric Notch2 expression and mouse incisor rotation. | 5.09e-06 | 2 | 79 | 2 | 10704869 | |
| Pubmed | Notch signaling is necessary but not sufficient for differentiation of dendritic cells. | 5.09e-06 | 2 | 79 | 2 | 12907456 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23589286 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 7689010 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 8917536 | ||
| Pubmed | Functional conservation of Notch1 and Notch2 intracellular domains. | 5.09e-06 | 2 | 79 | 2 | 15897231 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 25257945 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 30296524 | ||
| Pubmed | Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. | 5.09e-06 | 2 | 79 | 2 | 12753746 | |
| Pubmed | Mapping of a defined neurocan binding site to distinct domains of tenascin-C. | 5.09e-06 | 2 | 79 | 2 | 9341124 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26041884 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 10679933 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21771876 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15492845 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 29643502 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20346213 | ||
| Pubmed | Notch Inhibition Prevents Differentiation of Human Limbal Stem/Progenitor Cells in vitro. | 5.09e-06 | 2 | 79 | 2 | 31316119 | |
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 5.09e-06 | 2 | 79 | 2 | 24469451 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15616221 | ||
| Pubmed | A role for notch signaling in human corneal epithelial cell differentiation and proliferation. | 5.09e-06 | 2 | 79 | 2 | 17652726 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28158917 | ||
| Pubmed | Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas. | 5.09e-06 | 2 | 79 | 2 | 25041344 | |
| Pubmed | Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells. | 5.09e-06 | 2 | 79 | 2 | 25866967 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32423029 | ||
| Pubmed | Role of megalin and cubilin in the metabolism of vitamin D(3). | 5.09e-06 | 2 | 79 | 2 | 21595846 | |
| Pubmed | Notch2 signaling is required for potent antitumor immunity in vivo. | 5.09e-06 | 2 | 79 | 2 | 20351182 | |
| Pubmed | Differential distribution of cubilin and megalin expression in the mouse embryo. | 5.09e-06 | 2 | 79 | 2 | 14983511 | |
| Pubmed | Involvement of Notch in activation and effector functions of γδ T cells. | 5.09e-06 | 2 | 79 | 2 | 24489102 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 10024503 | ||
| Pubmed | The Notch pathway in podocytes plays a role in the development of glomerular disease. | 5.09e-06 | 2 | 79 | 2 | 18311147 | |
| Pubmed | Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. | 5.09e-06 | 2 | 79 | 2 | 25141821 | |
| Pubmed | Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans. | 5.09e-06 | 2 | 79 | 2 | 27197912 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 11108739 | ||
| Pubmed | Characterization of the L1-neurocan-binding site. Implications for L1-L1 homophilic binding. | 5.09e-06 | 2 | 79 | 2 | 10934197 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 9334227 | ||
| Pubmed | Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis. | 5.09e-06 | 2 | 79 | 2 | 26933171 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21693515 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18448595 | ||
| Pubmed | Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis. | 5.09e-06 | 2 | 79 | 2 | 27564686 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 25982147 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19701457 | ||
| Pubmed | Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma. | 5.09e-06 | 2 | 79 | 2 | 28820917 | |
| Pubmed | Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. | 5.09e-06 | 2 | 79 | 2 | 22006338 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19339697 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19915064 | ||
| Pubmed | Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. | 5.09e-06 | 2 | 79 | 2 | 27776108 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18666240 | ||
| Pubmed | In vivo mapping of notch pathway activity in normal and stress hematopoiesis. | 5.09e-06 | 2 | 79 | 2 | 23791481 | |
| Pubmed | Epidermal growth factor regulates NIKS keratinocyte proliferation through Notch signaling. | 5.09e-06 | 2 | 79 | 2 | 23899513 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 8636110 | ||
| Pubmed | 8.69e-06 | 210 | 79 | 6 | 16537572 | ||
| Pubmed | 8.98e-06 | 18 | 79 | 3 | 10827173 | ||
| Pubmed | 1.31e-05 | 132 | 79 | 5 | 26439863 | ||
| Pubmed | Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease. | 1.46e-05 | 21 | 79 | 3 | 27591083 | |
| Pubmed | 1.46e-05 | 21 | 79 | 3 | 17303760 | ||
| Pubmed | 1.50e-05 | 486 | 79 | 8 | 20936779 | ||
| Interaction | NTN5 interactions | 2.71e-14 | 24 | 79 | 8 | int:NTN5 | |
| Interaction | IGFL3 interactions | 1.39e-11 | 75 | 79 | 9 | int:IGFL3 | |
| Interaction | ZFP41 interactions | 2.45e-09 | 57 | 79 | 7 | int:ZFP41 | |
| Interaction | ZNF408 interactions | 5.40e-09 | 145 | 79 | 9 | int:ZNF408 | |
| Interaction | FOXD4L6 interactions | 3.66e-08 | 49 | 79 | 6 | int:FOXD4L6 | |
| Interaction | ZNF563 interactions | 1.06e-07 | 12 | 79 | 4 | int:ZNF563 | |
| Interaction | IGSF5 interactions | 2.12e-07 | 14 | 79 | 4 | int:IGSF5 | |
| Interaction | DEFB123 interactions | 3.84e-07 | 16 | 79 | 4 | int:DEFB123 | |
| Interaction | CCN6 interactions | 8.11e-07 | 19 | 79 | 4 | int:CCN6 | |
| Interaction | ZNF224 interactions | 1.01e-06 | 20 | 79 | 4 | int:ZNF224 | |
| Interaction | EGFL6 interactions | 1.24e-06 | 21 | 79 | 4 | int:EGFL6 | |
| Interaction | TIMP3 interactions | 1.43e-06 | 90 | 79 | 6 | int:TIMP3 | |
| Interaction | ANKRD36B interactions | 3.76e-06 | 60 | 79 | 5 | int:ANKRD36B | |
| Interaction | FEZF1 interactions | 4.17e-06 | 28 | 79 | 4 | int:FEZF1 | |
| Interaction | FBXO2 interactions | 4.59e-06 | 411 | 79 | 10 | int:FBXO2 | |
| Interaction | ZNF517 interactions | 4.82e-06 | 29 | 79 | 4 | int:ZNF517 | |
| Interaction | LRPAP1 interactions | 6.80e-06 | 180 | 79 | 7 | int:LRPAP1 | |
| Interaction | ZNF74 interactions | 9.27e-06 | 34 | 79 | 4 | int:ZNF74 | |
| Interaction | GREM2 interactions | 1.31e-05 | 37 | 79 | 4 | int:GREM2 | |
| Interaction | TAFA3 interactions | 1.37e-05 | 78 | 79 | 5 | int:TAFA3 | |
| Interaction | ZNF707 interactions | 1.46e-05 | 79 | 79 | 5 | int:ZNF707 | |
| Interaction | RSPO1 interactions | 2.55e-05 | 15 | 79 | 3 | int:RSPO1 | |
| Interaction | DKK2 interactions | 4.05e-05 | 49 | 79 | 4 | int:DKK2 | |
| Interaction | SMOC1 interactions | 5.96e-05 | 54 | 79 | 4 | int:SMOC1 | |
| Interaction | CASR interactions | 8.46e-05 | 22 | 79 | 3 | int:CASR | |
| Interaction | WNT2 interactions | 9.70e-05 | 23 | 79 | 3 | int:WNT2 | |
| Interaction | PLAT interactions | 1.09e-04 | 63 | 79 | 4 | int:PLAT | |
| Interaction | ZNF331 interactions | 1.09e-04 | 63 | 79 | 4 | int:ZNF331 | |
| Interaction | NCAN interactions | 1.11e-04 | 24 | 79 | 3 | int:NCAN | |
| Interaction | GOLGA8G interactions | 1.11e-04 | 24 | 79 | 3 | int:GOLGA8G | |
| Interaction | GLI4 interactions | 1.32e-04 | 125 | 79 | 5 | int:GLI4 | |
| Interaction | SHANK3 interactions | 1.38e-04 | 496 | 79 | 9 | int:SHANK3 | |
| Interaction | ZSCAN21 interactions | 1.48e-04 | 128 | 79 | 5 | int:ZSCAN21 | |
| Interaction | CNTN1 interactions | 1.56e-04 | 69 | 79 | 4 | int:CNTN1 | |
| Interaction | CILP interactions | 2.25e-04 | 6 | 79 | 2 | int:CILP | |
| Interaction | MBD1 interactions | 2.38e-04 | 77 | 79 | 4 | int:MBD1 | |
| Interaction | SLURP1 interactions | 2.56e-04 | 144 | 79 | 5 | int:SLURP1 | |
| Interaction | LGALS1 interactions | 3.25e-04 | 332 | 79 | 7 | int:LGALS1 | |
| Interaction | SOST interactions | 3.47e-04 | 35 | 79 | 3 | int:SOST | |
| Interaction | NID2 interactions | 3.64e-04 | 86 | 79 | 4 | int:NID2 | |
| Interaction | DLK2 interactions | 3.77e-04 | 36 | 79 | 3 | int:DLK2 | |
| Interaction | ZBTB48 interactions | 3.93e-04 | 158 | 79 | 5 | int:ZBTB48 | |
| Interaction | WNT10A interactions | 4.09e-04 | 37 | 79 | 3 | int:WNT10A | |
| Interaction | MDK interactions | 4.51e-04 | 91 | 79 | 4 | int:MDK | |
| Interaction | VLDLR interactions | 4.79e-04 | 39 | 79 | 3 | int:VLDLR | |
| Cytoband | 8q24.13 | 1.77e-03 | 36 | 79 | 2 | 8q24.13 | |
| GeneFamily | Low density lipoprotein receptors | 2.73e-10 | 13 | 55 | 5 | 634 | |
| GeneFamily | Fibronectin type III domain containing | 8.86e-06 | 160 | 55 | 6 | 555 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.69e-05 | 57 | 55 | 4 | 1179 | |
| Coexpression | NABA_CORE_MATRISOME | 1.58e-06 | 270 | 79 | 8 | MM17057 | |
| Coexpression | NABA_MATRISOME | HYAL4 SNED1 COL11A2 EGF MEGF6 TNC CCBE1 NCAN LAMA3 NID1 F2 LTBP4 MUC4 SVEP1 | 1.71e-06 | 1008 | 79 | 14 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | 1.82e-06 | 275 | 79 | 8 | M5884 | |
| Coexpression | NABA_MATRISOME | HYAL4 SNED1 COL11A2 EGF MEGF6 TNC CCBE1 NCAN LAMA3 NID1 F2 LTBP4 MUC4 SVEP1 | 2.11e-06 | 1026 | 79 | 14 | M5889 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.73e-06 | 35 | 79 | 4 | MM17054 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.47e-05 | 191 | 79 | 6 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.86e-05 | 196 | 79 | 6 | M3008 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 2.90e-05 | 20 | 79 | 3 | MM17053 | |
| Coexpression | MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN | 5.10e-05 | 24 | 79 | 3 | M1420 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 5.59e-05 | 135 | 79 | 5 | M5825 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 5.70e-05 | 325 | 79 | 7 | M39053 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN | 8.32e-05 | 76 | 79 | 4 | M8315 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | GABRG2 FLNC COL11A2 MEGF6 L1CAM CACNA1I ATAD2 GPR162 LTBP4 MUC4 ZNF292 | 8.62e-05 | 909 | 79 | 11 | M41018 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 9.10e-05 | 29 | 79 | 3 | MM17055 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.39e-04 | 261 | 79 | 6 | M1834 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.63e-04 | 385 | 79 | 7 | M39264 | |
| Coexpression | ELVIDGE_HYPOXIA_UP | 1.70e-04 | 171 | 79 | 5 | M7363 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 1.70e-04 | 171 | 79 | 5 | M8820 | |
| Coexpression | HOOI_ST7_TARGETS_UP | 1.82e-04 | 93 | 79 | 4 | M8455 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | ZCCHC18 VLDLR ZNRF3 TNC L1CAM LRP2 LRP4 CORIN EXOSC7 GINS1 NOTCH1 NOTCH2 EPHA7 | 5.88e-06 | 783 | 79 | 13 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.64e-08 | 189 | 79 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-08 | 190 | 79 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-08 | 190 | 79 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-08 | 191 | 79 | 7 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-08 | 191 | 79 | 7 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-08 | 193 | 79 | 7 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-08 | 195 | 79 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-08 | 195 | 79 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.16e-08 | 197 | 79 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.16e-08 | 197 | 79 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.60e-08 | 199 | 79 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.60e-08 | 199 | 79 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.60e-08 | 199 | 79 | 7 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-07 | 153 | 79 | 6 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-07 | 169 | 79 | 6 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-07 | 182 | 79 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-07 | 182 | 79 | 6 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-07 | 182 | 79 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-07 | 182 | 79 | 6 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.06e-07 | 183 | 79 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-07 | 183 | 79 | 6 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-07 | 184 | 79 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.65e-07 | 185 | 79 | 6 | eaa54b76743628c89b4310be57b87fa92b75fd37 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.65e-07 | 185 | 79 | 6 | f7f4c921d248c637351e2e882589b99ba7f04b66 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.65e-07 | 185 | 79 | 6 | ff38a15af3dec36d9993f06623591872b5d1da9a | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 187 | 79 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 187 | 79 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 187 | 79 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.06e-06 | 188 | 79 | 6 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 189 | 79 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 189 | 79 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.13e-06 | 190 | 79 | 6 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-06 | 190 | 79 | 6 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-06 | 190 | 79 | 6 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 191 | 79 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-06 | 191 | 79 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 191 | 79 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 191 | 79 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 192 | 79 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 192 | 79 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 192 | 79 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-06 | 192 | 79 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 192 | 79 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 193 | 79 | 6 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 194 | 79 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 194 | 79 | 6 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 194 | 79 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 194 | 79 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 194 | 79 | 6 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 194 | 79 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 195 | 79 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-06 | 195 | 79 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 195 | 79 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 195 | 79 | 6 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 195 | 79 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 196 | 79 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.35e-06 | 196 | 79 | 6 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 196 | 79 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-06 | 196 | 79 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 197 | 79 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.39e-06 | 197 | 79 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-06 | 197 | 79 | 6 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 197 | 79 | 6 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 197 | 79 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 197 | 79 | 6 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 197 | 79 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 197 | 79 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 197 | 79 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 198 | 79 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.43e-06 | 198 | 79 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.48e-06 | 199 | 79 | 6 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.52e-06 | 200 | 79 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.52e-06 | 200 | 79 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-06 | 200 | 79 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.52e-06 | 200 | 79 | 6 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.52e-06 | 200 | 79 | 6 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.52e-06 | 200 | 79 | 6 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.52e-06 | 200 | 79 | 6 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-06 | 200 | 79 | 6 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.52e-06 | 200 | 79 | 6 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-06 | 140 | 79 | 5 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.16e-06 | 158 | 79 | 5 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.16e-06 | 158 | 79 | 5 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-06 | 159 | 79 | 5 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-06 | 159 | 79 | 5 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-06 | 159 | 79 | 5 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 161 | 79 | 5 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 161 | 79 | 5 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 165 | 79 | 5 | 622aca1d49bd8c917b131e4f4959d9dba411d22b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-05 | 166 | 79 | 5 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 169 | 79 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 170 | 79 | 5 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 170 | 79 | 5 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-05 | 170 | 79 | 5 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 171 | 79 | 5 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 171 | 79 | 5 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-05 | 172 | 79 | 5 | 55fba5ce0ead1114e1a76f67ad68432c6bac90e5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 175 | 79 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 175 | 79 | 5 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 176 | 79 | 5 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| Computational | Adhesion molecules. | 7.83e-05 | 141 | 55 | 6 | MODULE_122 | |
| Computational | Genes in the cancer module 236. | 9.80e-05 | 18 | 55 | 3 | MODULE_236 | |
| Drug | monatepil | 4.92e-08 | 29 | 79 | 5 | CID000060810 | |
| Drug | 25-hydroxycholesterol | 1.41e-06 | 160 | 79 | 7 | CID000065094 | |
| Drug | chondroitin sulfate | 1.63e-06 | 413 | 79 | 10 | CID000024766 | |
| Drug | Epi Lovastatin | 2.80e-06 | 341 | 79 | 9 | CID000003962 | |
| Drug | pitavastatin | 2.85e-06 | 114 | 79 | 6 | CID005282451 | |
| Drug | sodium linoleate | 2.86e-06 | 342 | 79 | 9 | CID000003931 | |
| Drug | epicholesterol | 1.20e-05 | 636 | 79 | 11 | CID000000304 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.67e-05 | 155 | 79 | 6 | 6817_DN | |
| Drug | Rgd Peptide | 1.96e-05 | 239 | 79 | 7 | CID000104802 | |
| Drug | probucol | 2.14e-05 | 162 | 79 | 6 | CID000004912 | |
| Drug | Y 27632 | 2.70e-05 | 101 | 79 | 5 | ctd:C108830 | |
| Drug | mangrove | 3.49e-05 | 468 | 79 | 9 | CID000000965 | |
| Drug | hyaluronan | 3.62e-05 | 263 | 79 | 7 | CID000024759 | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 4.51e-05 | 185 | 79 | 6 | 5632_UP | |
| Drug | Calpain inhibitor I | 5.37e-05 | 280 | 79 | 7 | CID000004332 | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; MCF7; HT_HG-U133A | 5.55e-05 | 192 | 79 | 6 | 3391_UP | |
| Drug | ML 7 | 6.03e-05 | 61 | 79 | 4 | ctd:C070571 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.80e-05 | 61 | 75 | 4 | DOID:3587 (is_marker_for) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.91e-05 | 3 | 75 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.91e-05 | 3 | 75 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | pre-eclampsia (is_implicated_in) | 3.48e-05 | 25 | 75 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | Glioblastoma | 5.01e-05 | 79 | 75 | 4 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 6.37e-05 | 84 | 75 | 4 | C0334588 | |
| Disease | Colorectal Carcinoma | 7.18e-05 | 702 | 75 | 9 | C0009402 | |
| Disease | atherosclerosis (implicated_via_orthology) | 1.33e-04 | 7 | 75 | 2 | DOID:1936 (implicated_via_orthology) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.33e-04 | 7 | 75 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.33e-04 | 7 | 75 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.41e-04 | 103 | 75 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Intellectual Disability | 1.43e-04 | 447 | 75 | 7 | C3714756 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.81e-04 | 43 | 75 | 3 | EFO_0022290 | |
| Disease | Glioblastoma Multiforme | 1.88e-04 | 111 | 75 | 4 | C1621958 | |
| Disease | vascular endothelial growth factor A, isoform 121 measurement | 2.27e-04 | 9 | 75 | 2 | EFO_0020847 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 2.36e-04 | 47 | 75 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 2.83e-04 | 10 | 75 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | otitis media (is_marker_for) | 2.83e-04 | 10 | 75 | 2 | DOID:10754 (is_marker_for) | |
| Disease | phospholipids in very small VLDL measurement | 3.01e-04 | 51 | 75 | 3 | EFO_0022300 | |
| Disease | phospholipids in medium VLDL measurement | 3.19e-04 | 52 | 75 | 3 | EFO_0022154 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.24e-04 | 128 | 75 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.24e-04 | 128 | 75 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.24e-04 | 128 | 75 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.24e-04 | 128 | 75 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.24e-04 | 128 | 75 | 4 | C0007134 | |
| Disease | Sensory hearing loss | 3.45e-04 | 11 | 75 | 2 | C1691779 | |
| Disease | total lipids in medium VLDL | 3.56e-04 | 54 | 75 | 3 | EFO_0022153 | |
| Disease | vascular endothelial growth factor A measurement | 4.14e-04 | 12 | 75 | 2 | EFO_0010804 | |
| Disease | phospholipids in VLDL measurement | 4.63e-04 | 59 | 75 | 3 | EFO_0022301 | |
| Disease | Malignant neoplasm of skin | 4.63e-04 | 59 | 75 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 4.63e-04 | 59 | 75 | 3 | C0037286 | |
| Disease | phospholipids in small VLDL measurement | 4.86e-04 | 60 | 75 | 3 | EFO_0022146 | |
| Disease | total lipids in VLDL measurement | 4.86e-04 | 60 | 75 | 3 | EFO_0022314 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 4.88e-04 | 13 | 75 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Connective Tissue Diseases | 4.88e-04 | 13 | 75 | 2 | C0009782 | |
| Disease | gallbladder cancer (is_implicated_in) | 4.88e-04 | 13 | 75 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | free cholesterol in VLDL measurement | 5.11e-04 | 61 | 75 | 3 | EFO_0022276 | |
| Disease | Autistic Disorder | 5.43e-04 | 261 | 75 | 5 | C0004352 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.60e-04 | 148 | 75 | 4 | C0279702 | |
| Disease | triglycerides to total lipids in IDL percentage | 5.61e-04 | 63 | 75 | 3 | EFO_0022329 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 5.69e-04 | 14 | 75 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Spastic Paraplegia, Hereditary | 5.69e-04 | 14 | 75 | 2 | C0037773 | |
| Disease | cholesterol in large VLDL measurement | 6.15e-04 | 65 | 75 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 6.15e-04 | 65 | 75 | 3 | EFO_0022230 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 6.55e-04 | 15 | 75 | 2 | C0496930 | |
| Disease | Proteinuria | 6.55e-04 | 15 | 75 | 2 | HP_0000093 | |
| Disease | Benign neoplasm of bladder | 6.55e-04 | 15 | 75 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 6.55e-04 | 15 | 75 | 2 | C0154091 | |
| Disease | Alcohol abuse | 6.72e-04 | 67 | 75 | 3 | C0085762 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 6.72e-04 | 67 | 75 | 3 | EFO_0022245 | |
| Disease | sphingomyelin measurement | 7.22e-04 | 278 | 75 | 5 | EFO_0010118 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 7.33e-04 | 69 | 75 | 3 | EFO_0022341 | |
| Disease | level of triacylglycerol (56:6) in blood serum | 7.48e-04 | 16 | 75 | 2 | OBA_2020007 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 7.48e-04 | 16 | 75 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | Non-alcoholic Fatty Liver Disease | 7.64e-04 | 70 | 75 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 7.64e-04 | 70 | 75 | 3 | C3241937 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 7.96e-04 | 71 | 75 | 3 | EFO_0022259 | |
| Disease | Amphetamine-Related Disorders | 9.34e-04 | 75 | 75 | 3 | C0236733 | |
| Disease | behavioural disinhibition measurement | 9.34e-04 | 75 | 75 | 3 | EFO_0006946 | |
| Disease | Amphetamine Abuse | 9.34e-04 | 75 | 75 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 9.34e-04 | 75 | 75 | 3 | C0236804 | |
| Disease | Carcinoma of bladder | 9.50e-04 | 18 | 75 | 2 | C0699885 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.06e-03 | 19 | 75 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Nonsyndromic Deafness | 1.17e-03 | 81 | 75 | 3 | C3711374 | |
| Disease | Hemorrhage | 1.18e-03 | 20 | 75 | 2 | C0019080 | |
| Disease | cortisol measurement | 1.18e-03 | 20 | 75 | 2 | EFO_0005843 | |
| Disease | Neoplasm Invasiveness | 1.26e-03 | 184 | 75 | 4 | C0027626 | |
| Disease | Congenital diaphragmatic hernia | 1.30e-03 | 21 | 75 | 2 | C0235833 | |
| Disease | age-related hearing impairment | 1.43e-03 | 324 | 75 | 5 | EFO_0005782 | |
| Disease | Kidney Diseases | 1.48e-03 | 88 | 75 | 3 | C0022658 | |
| Disease | Sensorineural Hearing Loss (disorder) | 1.56e-03 | 23 | 75 | 2 | C0018784 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 1.56e-03 | 23 | 75 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | Malignant neoplasm of breast | 1.58e-03 | 1074 | 75 | 9 | C0006142 | |
| Disease | lipid measurement, lipoprotein measurement | 1.58e-03 | 90 | 75 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 1.70e-03 | 24 | 75 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 1.70e-03 | 24 | 75 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | Cerebral Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0750936 | |
| Disease | Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.84e-03 | 25 | 75 | 2 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0338070 | |
| Disease | acute necrotizing pancreatitis (biomarker_via_orthology) | 1.99e-03 | 26 | 75 | 2 | DOID:0080998 (biomarker_via_orthology) | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 1.99e-03 | 26 | 75 | 2 | OBA_2045191 | |
| Disease | brain cancer (implicated_via_orthology) | 1.99e-03 | 26 | 75 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 1.99e-03 | 26 | 75 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.99e-03 | 26 | 75 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.99e-03 | 26 | 75 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 2.15e-03 | 27 | 75 | 2 | C0334579 | |
| Disease | pancreatic cancer (is_marker_for) | 2.20e-03 | 101 | 75 | 3 | DOID:1793 (is_marker_for) | |
| Disease | obesity (implicated_via_orthology) | 2.22e-03 | 215 | 75 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.22e-03 | 215 | 75 | 4 | EFO_0008317, EFO_0008591 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKCTSDRNQGEECGY | 76 | Q96NH3 | |
| EKEAEDGIIAYDDCG | 451 | O75534 | |
| ELAENCVGYCGADIK | 626 | Q6PL18 | |
| GEITKEREDECFSCG | 2111 | Q96L73 | |
| KVLYHALCCDDEEGD | 191 | Q2T9L4 | |
| KSEDETEYGCRGSIC | 56 | Q9Y5P4 | |
| TFGRYCEGSEDACEE | 5066 | Q99102 | |
| CDLSDDAEYECQVGR | 101 | O60500 | |
| GYKGADCTEDVDECA | 406 | Q04721 | |
| GCADGEESDCLTEYE | 1311 | Q8IY17 | |
| EGYTGTHCEVDIDEC | 556 | P46531 | |
| DSGTCLDKIDGYECA | 651 | P46531 | |
| TRCYCEDGFEITEDG | 136 | Q9NZR2 | |
| CDGQKDCEDGRDEFH | 2701 | Q9NZR2 | |
| LKCNGEYDCADGSDE | 3611 | Q9NZR2 | |
| CDKGFYLDGSDTIVC | 256 | P15529 | |
| DSCDTCEDGYFALEK | 661 | Q16787 | |
| CDDYAEGRVCKVRFD | 356 | Q16538 | |
| GVCTADKDCEDAYRV | 46 | O75648 | |
| GKEVCYERLGCFSDD | 16 | P16233 | |
| TDDVYDEKGCQCDVS | 496 | Q9NR82 | |
| SCEEVEYFCNKGDDE | 56 | Q8WW38 | |
| CGRYGEYICDKTDED | 111 | Q5T1V6 | |
| GLGIEYDEDVVCDVC | 191 | Q9NQC1 | |
| FRGDGRTCYDIDECS | 701 | P14543 | |
| CSDCSADGKEQYERL | 106 | Q9H8E8 | |
| IECDDKGDGSCDVRY | 616 | Q14315 | |
| AAYESCEQKELECEG | 216 | P13942 | |
| ETYCLLIGGDDGACK | 381 | Q7Z3Z0 | |
| RDEGCGDAGDCTSLY | 231 | Q8IWV1 | |
| KVGEEDDGEYRCLAE | 301 | P32004 | |
| FVCDGDKDCVDGSDE | 1166 | P98164 | |
| SKTFVCDEDNDCGDG | 3046 | P98164 | |
| ALDKGCCFEDDETGA | 31 | A6NEQ2 | |
| KTYFSEEDVCGCLEA | 441 | Q86UT6 | |
| FSDKEGSSRCECEDG | 301 | Q15375 | |
| GRGCEDYRCVEVETD | 26 | Q15024 | |
| ASKYDDCEGGSVARC | 211 | O60494 | |
| KDVTCDLIVGCDGAY | 156 | O15229 | |
| FAGDGKLCSDIDECE | 861 | P01133 | |
| KLDDGDYLCEDGCQN | 641 | Q9Y6R7 | |
| IECDDKGDGSCDVRY | 621 | P21333 | |
| YECLAACEGSREIKD | 241 | O75718 | |
| RECCLSKDDVYDFGA | 291 | Q9P0X4 | |
| CREGYIREDDGKTCT | 161 | Q6UXH8 | |
| YEGADCREIKTADGC | 441 | Q2M3T9 | |
| DEEYGYECLDGKDCA | 401 | P18507 | |
| TFQCDGDEDCKDGSD | 396 | Q9Y5Q5 | |
| GYLDDCTCDVETIDR | 41 | Q96HE7 | |
| GFRGSACEEDVDECA | 701 | Q8N2S1 | |
| GLVYGKFCECDDREC | 171 | O95965 | |
| YRLSADGCGCEDVDE | 401 | O75095 | |
| YKCDLEDDCGDNSDE | 1136 | Q92673 | |
| KEYDECTSDGREDGR | 136 | Q9UBV2 | |
| YGGSFCEKDTEGCDR | 1076 | O14594 | |
| YTGCAKCGLELETDE | 696 | Q86V20 | |
| EEDCSCEGAKDGFQD | 1096 | Q9Y2K2 | |
| CDEGYRLEGSDKLTC | 466 | Q4LDE5 | |
| LGYTGLKCETDIDEC | 1221 | Q4LDE5 | |
| TGYEGAHCELERDEC | 781 | Q8TER0 | |
| KESGCSDTEYGCIAE | 31 | Q8TBZ0 | |
| RCDGVSDCKDGEDEY | 91 | P57727 | |
| SDCKDGEDEYRCVRV | 96 | P57727 | |
| NDLCAICLDEYEEGD | 306 | Q8WWF5 | |
| VCDDGYTGEDCRDRQ | 486 | P24821 | |
| EEDGVYKCDCEGCDR | 2251 | O60281 | |
| REEDNKYCADCEAKG | 26 | Q8IYB5 | |
| CGEQRGEDCAELHDY | 211 | Q495A1 | |
| DDFSDCYIECVIRGE | 66 | Q96MM3 | |
| YECKECGEAFICGAD | 226 | Q8N141 | |
| YCGEEGHSKETCDNE | 351 | P0CG32 | |
| SDCAICLEKYIDGEE | 291 | Q9ULT6 | |
| DSAGERACKCDVYDK | 391 | A6NK53 | |
| EKRYECDDCGGTFRS | 166 | Q8NB50 | |
| CDLNYCEEAVEEETG | 286 | P00734 | |
| ESDVRVCDESSCKYG | 71 | Q8IYR6 | |
| RCLKDYGEFEVDDGT | 151 | Q14691 | |
| VGKDCRDGFYEAELC | 91 | Q04206 | |
| GSDDLLIKCEEYDGE | 356 | O43164 | |
| ERRYECAACGKVFGD | 471 | Q96PQ6 | |
| CKDLVIGYECDCAAG | 371 | P98155 | |
| IGYECDCAAGFELID | 376 | P98155 | |
| CESEEKEDGGGCYDI | 911 | P35573 | |
| RDYLGDDGLCGEEEK | 181 | Q2WGJ6 | |
| DREYDCKDMSDEVGC | 256 | P01130 | |
| YCDGDTDCKDGSDEE | 166 | O75096 | |
| GRCILDIYHCDGDDD | 201 | O75096 |